Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Blood (2018) 132 (Supplement 1): 4346.

https://doi.org/10.1182/blood-2018-99-119712

Published: 2018

Journal Articles

UTX mutations in Myeloid Neoplasms

Yasunobu Nagata, MD,PhD, Tomas Radivoyevitch, PhD, Hideki Makishima, MD PhD FACP., Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Teodora Kuzmanovic, BSc, Eiju Negoro, MD, PhD, Michael J. Clemente, M.S., Sudipto Mukherjee, MD, PhD, M.P.H., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 3148.

https://doi.org/10.1182/blood.V128.22.3148.3148

Published: 2016

Journal Articles

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

Vera Adema, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Aziz Nazha, MD, Teodora Kuzmanovic, Eiju Negoro, MD, PhD, Dewen You, PhD, Hideki Makishima, MD PhD FACP., Michael J. Clemente, M.S., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 3155.

https://doi.org/10.1182/blood.V128.22.3155.3155

Published: 2016

Journal Articles

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Eiju Negoro, MD, PhD, Michael Clemente, M.S., Naoko Hosono, MD,PhD, Aziz Nazha, MD, Wenyi Shen, MD, Yasunobu Nagata, MD, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Reda Z. Mahfouz, MD, PhD, Teodora Kuzmanovic, BSc, Hideki Makishima, MD PhD FACP., Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4290.

https://doi.org/10.1182/blood.V128.22.4290.4290

Published: 2016

Journal Articles

Clinical Effects of IDH1/2-Mutant Inhibitors in IDH1/ 2-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: Suggestions from Ex Vivo Experiments

Remco Molenaar, M.Sc., Tomas Radivoyevitch, PhD, Mohammed Khurshed, MD, Eiju Negoro, MD, PhD, Bartlomiej P Przychodzen, MSc, Hetty E. Carraway, MD MBA, Cornelis J van Noorden, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4308.

https://doi.org/10.1182/blood.V128.22.4308.4308

Published: 2016

Journal Articles

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Blood (2016) 128 (22): 957.

https://doi.org/10.1182/blood.V128.22.957.957

Published: 2016

Journal Articles

Molecular Predictors of Response in Patients with Myeloid Neoplasms Treated with Lenalidomide

Eiju Negoro, MD PhD, Chantana Polprasert, MD, Tomas Radivoyevitch, PhD, Vera Adema, Naoko Hosono, MDPhD, Hideki Makishima, MD PhD, Bartlomiej Przychodzen, MSc, Mikkael A. Sekeres, MD MS, Valeria Santini, MD, Kathy McGaw, Alan F. List, MD, Francesc Sole, PhD, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 2853.

https://doi.org/10.1182/blood.V126.23.2853.2853

Published: 2015

Journal Articles

Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)

Eiju Negoro, MD PhD, Naoko Hosono, MDPhD, Wenyi Shen, MD, Tetsuichi Yoshizato, MD, Bhumika J. Patel, Cassandra Hirsh, BSc, Bartlomiej Przychodzen, MSc, Michael J. Clemente, Reda Z. Mahfouz, MDPhD, Aleksandra Wodnar-Filipowicz, PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 1652.

https://doi.org/10.1182/blood.V126.23.1652.1652

Published: 2015

NARROW

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

UTX mutations in Myeloid Neoplasms

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Clinical Effects of IDH1/2-Mutant Inhibitors in IDH1/ 2-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: Suggestions from Ex Vivo Experiments

Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

Molecular Predictors of Response in Patients with Myeloid Neoplasms Treated with Lenalidomide

Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only